AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 0.48 |
Market Cap | 12.53M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -1.19 |
PE Ratio (ttm) | -0.42 |
Forward PE | n/a |
Analyst | Buy |
Ask | 0.5 |
Volume | 309,841 |
Avg. Volume (20D) | 677,500 |
Open | 0.50 |
Previous Close | 0.50 |
Day's Range | 0.47 - 0.52 |
52-Week Range | 0.38 - 1.94 |
Beta | undefined |
About SNSE
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment Activated Biologics, a platform designed to unleash the anti-tumor po...
Analyst Forecast
According to 3 analyst ratings, the average rating for SNSE stock is "Buy." The 12-month stock price forecast is $4, which is an increase of 703.21% from the latest price.